Podcasts about gynecology

Your clinic told you donor eggs. You walked out wondering how much time you actually have left. Whether waiting six months means missing your window. Whether trying with your own eggs one more time is brave or stupid. The honest answer is longer than your clinic implied. And the window is not your AMH number. In this episode: - Why a 2024 study in Archives of Gynecology and Obstetrics found that ovarian reserve markers like AMH do not significantly predict natural conception in women with regular cycles - What the 90-day window before ovulation actually is, and why the eggs you work with six months from now are not the eggs you are working with today - The inputs your clinic's timeline assumed would not change: mitochondrial function, inflammation, iron, B12, zinc, vitamin D, cortisol patterns, toxic load - The clinical pattern we see over more than a decade of cases: month zero to six is where the picture comes into view, twelve to eighteen months is where it can start to move substantially - Why some pictures do not move, and why that is still a reason to look before you decide If this is the first episode you have landed on in this series, go back and listen to "Told Donor Eggs Are Your Only Option? Ask This First" and then "The Gut Findings Your Clinic Did Not Look For." This episode builds on both. ——— WHAT YOUR CLINIC MISSED The full thyroid panel, not just a TSH. The iron panel that flags ferritin. The gut microbiome testing that your REI does not order. The inflammatory markers no one notices. The male side that almost no one investigates. Email hello@fabfertile.ca, subject line MISSED, and we will send you the guide. ——— FUNCTIONAL FERTILITY SECOND OPINION A free 45-minute call where I review your labs, your history, and your partner's results with you. You leave knowing what your biology has been telling you and what your next decision could be. Email hello@fabfertile.ca, subject line FERTILE, or book here. ——— ABOUT THE HOST Now in its eighth year, Get Pregnant Naturally was one of the first podcasts dedicated to the functional fertility approach for low AMH and failed IVF. Hosted by Sarah Clark, founder of Fab Fertile, author of Fabulously Fertile, and host of a podcast with over one million downloads. Fab Fertile is a functional fertility team that works with couples to review the lab work most fertility clinics do not run: gut microbiome, food sensitivity, vaginal microbiome, nutrigenomics, HTMA, DUTCH, full thyroid panel, the iron panel, and inflammation markers, alongside nervous system work. Each week Sarah brings you what the team sees across more than a decade of cases. Sarah Clark, founder of Fab Fertile, host of Get Pregnant Naturally (1M+ downloads), and author of Fabulously Fertile. ——— If this episode helped, leave a review on Apple Podcasts. It is how other women find this work. ——— TIMESTAMPS 00:00 The Donor Egg Recommendation and the Real Question 01:00 Who's Reviewing Your Case at Fab Fertile 01:30 AMH Is Not the Countdown Clock 03:00 The 90-Day Window Before Ovulation 04:30 What Actually Changes In 90 Days 07:00 The Fab Fertile Method: What We Investigate 08:30 Why Some Cases Do Not Shift 09:30 The Functional Fertility Second Opinion

Welcome back, everyone. Today we're diving into one of the most hotly debated topics in obstetrics- should we be treating preeclampsia without severe features with antihypertensive medications during expectant management? Now, if you've been following the literature- and our show, you know that the landmark CHAP trial changed the game for chronic hypertension in pregnancy. It showed us that targeting a blood pressure below 140 over 90 reduces serious maternal complications, without harming the baby. That was a big deal. But here's the thing, CHAP studied chronic hypertension. Then there was the CHIP trial- that also found that tight control of gestational hypertension and nonproteinuric chronic hypertension was also beneficial. These did not address preeclampsia without severe features, and yet, the ripple effects of that trial have sparked a global conversation about whether we should be extending those same treatment principles to women with preeclampsia who don't yet have severe features. And this is where it gets really interesting, because the guidelines don't agree. In the United States, ACOG and the Society for Maternal-Fetal Medicine still say: hold off on antihypertensives unless blood pressures hit the severe range at 160/110. But step outside the US, and you'll find the World Health Organization, the International Society for the Study of Hypertension in Pregnancy, FIGO, NICE, and Hypertension Canada all recommending treatment at 140 over 90, regardless of whether the diagnosis is chronic hypertension, gestational hypertension, or preeclampsia. So who's right? And more importantly what does this mean for the patient sitting in front of you right now, at 34 weeks, with a blood pressure of 150 over 95, some proteinuria, but no severe features? Today, we're going to break this down. We'll review the controversy, walk through the divergent guidelines, and most importantly talk about the real, practical implications that favor treating these patients during expectant management. Because when you're watching someone with preeclampsia, waiting for the right time to deliver, there's a strong argument that controlling their blood pressure isn't just reasonable…may be protective. So grab your coffee, settle in, and let's get into it.1. Society for Maternal-Fetal Medicine Statement: Antihypertensive Therapy For mild chronic Hypertension in Pregnancy-The Chronic Hypertension And Pregnancy Trial. American Journal of Obstetrics and Gynecology. 2022. Society for Maternal-Fetal Medicine; Publications Committee. 2. Preeclampsia. The New England Journal of Medicine. 2022. Magee LA, Nicolaides KH, von Dadelszen P.3. Antihypertensive Drug Therapy for Mild to Moderate Hypertension During Pregnancy.The Cochrane Database of Systematic Reviews. 2018. Abalos E, Duley L, Steyn DW, C.4. Prevention and Treatment of Maternal Stroke in Pregnancy and Postpartum: A Scientific Statement From the American Heart Association. Stroke. 2026. Miller EC, Bello NA, Chen PR, et al.5.Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022. Garovic VD, Dechend R, Easterling T, et al.

Welcome to Fertility & Sterility Roundtable, hosted by Dr. Emily Barnard and Dr. Ben Peipert! Each week, we will host a discussion with the authors of "Views and Reviews" and "Fertile Battle" articles published in a recent issue of Fertility & Sterility.  Today, we will be discussing the Fertile Battle episode from the April 2026 edition of Fertility and Sterility entitled "Is Concurrent Gestational Surrogacy an Ethical Practice?" Concurrent surrogacy involves two gestational carriers being engaged simultaneously—or whose pregnancies overlap—to allow a single intended parent or couple to have children born without the usual spacing between births  Dr. Michelle Bayefsky is a second year Reproductive Endocrinology and Infertility fellow at the Icahn School of Medicine at Mount Sinai. She has written a book and more than 30 peer-reviewed papers on issues related to reproductive ethics and fertility preservation. She is currently a member of the ASRM Ethics Committee. For the purposes of this discussion, Dr. Bayefsky authored the Pro side of the argument that concurrent gestational surrogacy is an ethical practice.  Dr. Caroline Violette is a second year Reproductive Endocrinology & Infertility Fellow at Brown University. Prior to fellowship, Dr. Violette obtained her medical degree from Emory University School of Medicine and completed her residency in Obstetrics and Gynecology at the University of Southern California. Her research interests include oncofertility and addressing healthcare disparities related to access to fertility treatment in the United States. For the purposes of this discussion, Dr. Violette authored the "con" side of the argument that these concurrent surrogacy arrangements are unethical.  Dr. Arthur Caplan is a Professor and founding head of the Division of Medical Ethics at NYU School of Medicine in New York City. Dr. Caplan has served on a number of national and international committees, including chair of the Advisory Committee to the United Nations on Human Cloning, a member of the advisory committee to the International Olympic Committee on genetics and gene therapy, and co-director of the Joint Council of Europe/United Nations Study on Trafficking in Organs and Body Parts. He is the author or editor of thirty-five books and over 890 papers in peer reviewed journals. Dr. Caplan authored the pro side of the argument.  Read the Fertile Battle from Volume 125, Issue 4 p598-604 in the April 2026 issue View Fertility and Sterility at https://www.fertstert.org/  

Common But Not Normal: Treating Pelvic Organ Prolapse Maintaining an active lifestyle is vital for healthy aging, but conditions like pelvic organ prolapse can abruptly isolate individuals and disrupt daily life. This condition occurs when weakened pelvic floor muscles can no longer support surrounding organs, leading to symptoms like bladder leakage, bowel difficulties, and physical discomfort. Our experts debunk common misconceptions, offer treatment options, and emphasize the importance of pelvic health awareness. Guests: Dr. Savitha Krishnan, urogynecologist, El Camino Health Jane, prolapse patient   Astrology Pt.2: Is Your Health And Success Written In The Stars? Though astrology was removed from academia in the 17th century, the ancient practice has experienced a massive modern resurgence. Data shows that public belief in its scientific merit has remained steady since the 1980s. This segment explores the enduring cultural power of astrology, the varying definitions of what makes something "Scientific," and why millions of people still rely on the stars. Guests:  Neda Farr, celebrity astrologer, creator, Starcrossed App Steven Vanden Broecke, Ph.D., professor of history of science, Ghent University Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Common But Not Normal: Treating Pelvic Organ Prolapse Maintaining an active lifestyle is vital for healthy aging, but conditions like pelvic organ prolapse can abruptly isolate individuals and disrupt daily life. This condition occurs when weakened pelvic floor muscles can no longer support surrounding organs, leading to symptoms like bladder leakage, bowel difficulties, and physical discomfort. Our experts debunk common misconceptions, offer treatment options, and emphasize the importance of pelvic health awareness. Guests:  Dr. Savitha Krishnan, urogynecologist, El Camino Health Jane, prolapse patient Host and Producer: Kristen Farrah   Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this re-aired episode, HeHe sits down with Dr. Heather Florescue for an incredibly important and deeply educational conversation about stillbirth prevention, placental health, and the warning signs families deserve to know during pregnancy. Together, they unpack why conversations around stillbirth are so often avoided, how education can empower—not scare—parents, and what proactive care can look like when we truly prioritize maternal and fetal health. Dr. Florescue explains the role of placental function in pregnancy outcomes, why estimated placental volume matters, and how recognizing changes in fetal movement and maternal intuition can be life-saving. She also shares current research, discusses risk factors that are often overlooked, and highlights protocols used in places like the UK and Australia that have helped reduce stillbirth rates through earlier intervention and better patient education. This episode is not about fear. It's about informed awareness, advocacy, and helping families understand that paying attention to your body and your baby matters. If you've ever felt dismissed during pregnancy or wondered whether you were “overreacting” to a concern, this conversation is such an important reminder that your instincts deserve to be heard.   Guest Bio: Dr. Florescue is an ob.gyn. in private practice at Women Gynecology and Childbirth Associates in Rochester, N.Y. She delivers babies at Highland Hospital in Rochester, NY.  She received her medical degree at the University of Rochester School of Medicine & Dentistry, completed her internship and residency in obstetrics & gynecology at the University of Rochester Medical Center.  She is certified by the American Congress of Obstetrics & Gynecology.  She and her husband are parents to a set of triplets.  Dr. Florescue is passionate about the prevention of pregnancy and infant loss and the care for families who suffer these terrible tragedies.  SOCIAL MEDIA: Connect with HeHe on Instagram: https://www.instagram.com/tranquilitybyhehe/  Connect with Dr. Florescue on IG: https://www.instagram.com/drflorescueobgyn/  BIRTH EDUCATION: Learn how to stay in control of your birth and reduce the risk of unnecessary interventions in our Avoid a C-Section Webinar. HeHe breaks down the cascade of interventions, explains what's really happening in the hospital, and shares practical strategies to protect your birth plan, advocate for yourself, and navigate labor with confidence. Perfect for anyone who wants a positive, informed hospital birth experience: https://www.thebirthlounge.com/csection Feeling nervous about speaking up in labor? Our Scripts for Advocacy give you the exact words to handle the most common conversations that can make or break your birth experience. From declining unnecessary interventions to asking the right questions about procedures, these scripts empower you to stay in control, speak confidently, and protect your birth plan — even when the pressure is on. Think of it as your personal toolkit for advocating like a pro, so you can focus on your baby, not the stress: https://www.thebirthlounge.com/Scripts-for-Advocacy And if you haven't grabbed it yet… Snag my free Pitocin Guide to understand the risks, benefits, and red flags your provider may not be telling you about, so you can make informed, powerful decisions in labor: https://www.thebirthlounge.com/pitocin Join The Birth Lounge for judgment-free, evidence-based childbirth education from HeHe that shows you exactly how to navigate hospital policies, avoid unnecessary interventions, and have a trauma-free labor experience, all while feeling wildly supported every step of the way: https://www.thebirthlounge.com/ Want prep delivered straight to your phone? Download The Birth Lounge App for bite-sized birth and postpartum tools you can use anytime, anywhere: https://www.thebirthlounge.com/app   LINKS MENTIONED: Star Legacy Foundation: https://starlegacyfoundation.org/ Count the Kicks: https://countthekicks.org/ PUSH Pregnancy: https://www.pushpregnancy.org/ Tommys.org: https://www.tommys.org/pregnancy-information Saving Babies Lives Care Bundles: https://www.england.nhs.uk/wp-content/uploads/2019/03/Saving-Babies-Lives-Care-Bundle-Version-Two-Updated-Final-Version.pdf

The American College of Obstetricians and Gynecologists (ACOG) does not recommend routine ultrasound measurement of the lower uterine segment (LUS) thickness as part of the evaluation for trial of labor after cesarean delivery (TOLAC). ACOG Practice Bulletin No. 205 (2019) on Vaginal Birth After Cesarean Delivery does not include LUS measurement among its recommendations for TOLAC candidacy assessment. The guideline focuses on clinical factors such as type of prior uterine incision, number of prior cesarean deliveries, and other obstetric history to determine TOLAC candidacy, and emphasizes that most women with one previous low-transverse cesarean delivery should be counseled about and offered TOLAC. But what if you find a likely uterine window at the LUS? Does that mandate a repeat C-section? This topic comes from Serena, one of our podcast family members. Listen in for details. 1. Dr. Chapa's Clinical Pearls, Dec 31., 2023: LUST FOR TOLAC; and follow up episode Jan 15, 20242. ACOG Practice Bulletin No. 205: Vaginal Birth After Cesarean Delivery. Committee on Practice Bulletins—Obstetrics Obstetrics and Gynecology. 2019;133(2):e110-e127. doi:10.1097/AOG.0000000000003078.3. Rozenberg P, Sénat MV, Deruelle P, et al. Evaluation of the Usefulness of Ultrasound Measurement of the Lower Uterine Segment Before Delivery of Women With a Prior Cesarean Delivery: A Randomized Trial. American Journal of Obstetrics and Gynecology. 2022. 4. Swift BE, Shah PS, Farine D. Sonographic Lower Uterine Segment Thickness After Prior Cesarean Section to Predict Uterine Rupture: A Systematic Review and Meta-Analysis. Acta Obstetricia Et Gynecologica Scandinavica. 2019. 5. McLeish SF, Murchison AB, Smith DM, et al. Predicting Uterine Rupture Risk Using Lower Uterine Segment Measurement During Pregnancy With Cesarean History: How Reliable Is It? A Review. Obstetrical & Gynecological Survey. 2023. 6. Jastrow N, Demers S, Chaillet N, et al. Lower Uterine Segment Thickness to Prevent Uterine Rupture and Adverse Perinatal Outcomes: A Multicenter Prospective study.7. American Journal of Obstetrics and Gynecology. 2016. 8. Guerby P, Bujold E, Chaillet N. Impact of Third-Trimester Measurement of Low Uterine Segment Thickness and Estimated Fetal Weight on Perinatal Morbidity in Women With Prior Cesarean Delivery. Journal of Obstetrics and Gynaecology Canada. JOGC. 2022.

Catherine Birndorf, MD, is a Reproductive Psychiatrist, the Co-Founder, CEO, and Medical Director of The Motherhood Center of New York. Dr. Birndorf is the Founding Director of the Payne Whitney Women's Program at Weill Cornell Medicine – New York-Presbyterian Hospital. In addition, she is a Clinical Associate Professor of Psychiatry and Obstetrics & Gynecology. A graduate of Smith College, Dr. Birndorf attended Brown University Medical School and did her Psychiatry Residency at New York-Presbyterian Hospital. A past Postpartum Support International board member, Dr. Birndorf now serves on the President's Advisory Council. For ten years, Dr. Birndorf was a regular mental health columnist for Self Magazine and has appeared on numerous television programs, including The TodayShow, Good Morning America, MSNBC, and CNN. Dr. Birndorf recently consulted on a special postpartum episode of Law & Order. Dr. Birndorf's first book, The Nine Rooms of Happiness, was an NYTimes bestseller published in 2010. Her most recent book, published by Simon &Schuster in 2019, is entitled What No One Tells You: A Guide to Your Emotions from Pregnancyto Motherhood.Dr. Birndorf joins us on The Vault to dispel myths around antidepressant use during and after pregnancy, to discuss how hormones play a role in our mental health and wellbeing and to discuss the unique challenges and treatments for women's mental health. She also discusses how men may struggle during the postpartum period and how those trying to become pregnant have their own unique challenges with regard tomental health. How to diagnosis postpartum depression. How men struggle in the postpartum period Infertility and mental health. How treat postpartum depression. What causes postpartum depression? Can I take antidepressants during pregnancy? How to diagnosis OCD in pregnancy? How to cope with burnout as a Physician. How to Cope with High Functioning Depression.Follow Dr. Birndorf and Learn more about The Motherhood Center.Dr. Cathrine Birndorf Instagram https://www.instagram.com/drcatherinebirndorf/The Motherhood Center https://themotherhoodcenter.com/Dr. Catherine Birndorf's Books:The Nine Rooms Of HappinessWhat No One Tells You: A Guide to Your Emotions From Pregnancy to Motherhood and Beyond. Follow Dr. Judith:Instagram: https://instagram.com/drjudithjoseph TikTok: https://www.tiktok.com/@drjudithjoseph Facebook: https://www.facebook.com/drjudithjoseph Website: https://www.drjudithjoseph.com/Sign up for my newsletter here: https://www.drjudithjoseph.com/newsletter-sign-upDisclaimer: You may want to consider your individual mental health needs with a licensed medical professional. This page is not medical advice.

If Part 1 was about the field of sexual medicine, Part 2 is about the marriage at the center of it. Dr. Jenni Skyler and Daniel Lebowitz return to their conversation with Dr. Irwin and Sue Goldstein, and this time, the questions get more personal. How do you stay married for fifty years? What does great sex actually look like across the decades? And what happens when a woman who has spent her career in sexual medicine starts experiencing low desire herself? Sue Goldstein opens up about her own journey through peri-menopause and the slow erosion of her libido- what she calls "duty sex", and the medications that brought not just her sex drive back, but a playfulness in her marriage she hadn't realized had gone missing. She walks listeners through her menopause toolbox of five treatments, explains why she's "76 and feels like she's in her 50s", and dismantles the lingering fears from the Women's Health Initiative that have kept generations of women in what she calls hormone prison. Dr. Irwin shares his own daily protocols for sexual health, why he believes most older men are leaving capacity on the table, and the surprising data from their own clinic- that more than half the Vyleesi prescriptions they write are off-label for men. They explore why dopamine is dopamine, regardless of gender. The reality of persistent genital arousal disorder. And a remarkable story of a teenage horseback rider whose chronic arousal turned out to be a herniated disc. This episode is full of practical wisdom, clinical innovation, and one of the most real conversations about long-term love you'll hear all year. The Goldsteins' secret to fifty years of marriage? Best friends, good sex, and the willingness to keep trying new things — including a chocolate sauce on the day before you change the sheets. Irwin Goldstein, MD, IF (he/him/his). Director, San Diego Sexual Medicine 5555 Reservoir Drive, Suite 300, San Diego, CA 92120, Director, Sexual Medicine, UC San Diego Health East Campus, San Diego, CA. Clinical Professor of Urology, University of California at San Diego. Voluntary Clinical Professor of Obstetrics, Gynecology and Reproductive Services Past President, International Society for the Study of Women’s Sexual Health. Past President, Sexual Medicine Society of North America. Editor Emeritus, Sexual Medicine Reviews, The Journal of Sexual Medicine, International Journal of Impotence Research. Phone: 619 265-8865 - Mobile: 619 987-7432. Email: dr.irwingoldstein@gmail.com. http://www.sandiegosexualmedicine.com. Like us on Facebook: https://www.facebook.com/SDSexMed. X: http://twitter.com/SDSexualMedSee omnystudio.com/listener for privacy information.

OA1264 - Sherise Doyley was in the early stages of labor, in a hospital bed, preparing to deliver her baby, when nurses wheeled in a computer. On the screen was a judge, notifying her of an emergency order by the State of Florida to attempt to force her to undergo a C-section, instead of first attempting vaginal delivery. For 3 hours she advocated for herself, without an attorney, barely covered in a hospital gown. How was any of this legal? What is happening? Jenessa breaks down the history of our rights to make our own medical decisions and how that is legally modified in pregnancy, Lydia shares her own birth experience and how these situations could be handled with actual compassion, and Thomas holds very still in hopes our eyes are based on movement (just kidding, Thomas is very supportive and also outraged). Come rage against the machine with us and hopefully breathe life into a revived pro-choice movement, before it's too late. Amy Yurkanin (Mar. 14, 2026), They Didn't Want to Have C-Sections. A Judge Would Decide How They Gave Birth, ProPublica. Video clips of Doyley hearing, provided by ProPublica's Facebook page Anuli Njoku, Marian Evans, Lillian Nimo-Sefah, & Jonell Bailey (2023). Listen to the Whispers before They Become Screams: Addressing Black Maternal Morbidity and Mortality in the United States, 11 Healthcare 438. Brad N. Greenwood, Rachel R. Hardeman, Laura Huang, & Aaron Sojourner (2020), Physician–patient racial concordance and disparities in birthing mortality for newborns, 117 Proceedings of the National Academy of Sciences 21194. Maternal Mortality Prevention (Dec. 18, 2025). Data from the Pregnancy Mortality Surveillance System, CDC. Bracey Harris & Elizabeth Chuck (Jan. 9, 2026), 'Her worst fear has come to pass': Midwife who advocated for Black women dies after giving birth, NBC News. Camila Domonoske (Apr. 17, 2018), 'Father Of Gynecology,' Who Experimented On Slaves, No Longer On Pedestal In NYC, NPR. Megan L. Swanson, Sara Whetstone, Tushani Illangasekare, & Amy (Meg) Autry (2021), Obstetrics and Gynecology and Reparations: The Debt We Owe (and Continue to Accumulate), 5 Health Equity 353. Nicole Loy (May 16, 2025), Pain and Gynecology: Raising Standards of Care, The Healthcare Review at Cornell University. Jess Mador (July 29, 2025), A Brain-Dead Pregnant Woman Was Kept Alive in Georgia. It's Unclear if State Law Required It, KFF Health News. (June 2025), Pregnancy Exceptionalism: A Review of Restrictions on Advance Directives, Pregnancy Justice. U.S. Const. amend. IX Jacobson v. Massachusetts, 197 U.S. 11 (1905) Rochin v. California, 342 U.S. 165 (1952) Cruzan v. Director, Missouri Dep't of Health, 497 U.S. 261 (1990) Washington v. Harper, 494 U.S. 210 (1990) Roe v. Wade, 410 U.S. 113 (1973) Planned Parenthood of Southeastern Pa. v. Casey, 505 U.S. 833 (1992) Dobbs v. Jackson Women's Health Organization, 597 U.S. 215 (2022) Heller v. Doe, 509 U.S. 312 (1993) State Dept. of Human Services v. Northern, 563 S.W.2d 197 (1978) Lane v. Candura, 6 Mass. App. Ct. 377 (1978) Koskenoja v. Whitmer, Mich. Ct. Cl. (2026) (Apr. 20, 2026), Michigan Pregnancy Exclusion Law is Unconstitutional, Compassion & Choices. Check out the OA Linktree for all the places to go and things to do!  

Outside of pregnancy, guidelines emphasize diabetes self-management education and support to facilitate informed decision making, self-care behaviors, problem solving, and active collaboration with health care professionals. This includes, in those with good health literacy, the concept of patient-led self-titration of basal insulin results which has data that it improves glycemic management compared with clinician-led titration for type 2 diabetes among nonpregnant adults. But what about for GDM? Can patient's self manage their BASAL insulin? In this episode, we will review a new RCT published in April 2026 in the Green Journal on this very subject. As novel as this is, it is not the first to report on this as it was also published (retrospective study in the UK) in 2022. This is a novel approach to insulin in GDM but there are some questions that remain. Listen in for details.1. Boonpattharatthiti K, Wechkunanukul K, Mayang N, et al . Comparison of Insulin Titration Strategies for Glycemic Control in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.Diabetes Care. 2025. 2. Valent, Amy M. DO, MCR; Barbour, Linda A. MD, MSPH. Insulin Management for Gestational and Type 2 Diabetes in Pregnancy. Obstetrics & Gynecology 144(5):p 633-647, November 2024. | DOI: 10.1097/AOG.00000000000056403. Wang, Xiao-Yu MD; Gabbe, Steven MD; Landon, Mark B. MD; Venkatesh, Kartik K. MD, PhD et al. Patient-Led Insulin Titration for Glycemic Management With Gestational Diabetes Mellitus: A Randomized Controlled Trial. Obstetrics & Gynecology 147(4):p 501-509, April 2026. 4. McGovern AP, Hirwa KD, Wong AK, et al. Patient-led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweight. Diabet Med. 2022;39:e14926. doi: 10.1111/dme.14926

Gina, a perinatal fitness trainer, birth doula, and founder of MamasteFit in North Carolina, explains how exercising during pregnancy improves quality of life during pregnancy and postpartum—not just birth outcomes—while noting prenatal exercise research is still limited. She highlights a 2025/2026 American Journal of Obstetrics and Gynecology systematic review (11 RCTs) finding the strongest biomarker benefits from 12+ week programs done 2–3 times/week at moderate-to-vigorous intensity, including reduced pro-inflammatory markers, improved glucose/insulin regulation (supporting lower gestational diabetes risk), better lipid regulation, and favorable hormone/growth-factor changes linked to placental function and possibly baby brain development. Another 2025 review (9 RCTs, 1,500+ participants) suggests strength training may reduce excessive weight gain, low back/sciatic pain, and improve mood, sleep, fatigue, and well-being. She also cites studies indicating high-intensity lifting and even Valsalva can be well-tolerated with adequate rest and self-monitoring, then outlines MamasteFit's endurance-focused programming (compound lifts, accessory multi-plane work, myofascial slings, and posterior-chain emphasis) and promotes their app/video programs with a discount code.00:00 Why Prenatal Exercise Matters00:46 Meet Gina and MamasteFit01:38 What Research Can Tell Us02:23 Biomarkers and Training Dose05:11 Inflammation and Glucose Control08:05 Lipids Hormones and Baby Brain10:46 Strength Training Quality of Life13:17 Heavy Lifting and Valsalva Safety18:03 Listening to Your Body18:58 How to Program Prenatal Lifting20:54 Movement Variety and Posterior Chain23:04 Programs and Final Takeaways————

Dr. Irwin Goldstein didn't set out to become a pioneer of sexual medicine. He was a biomedical engineer turned urology resident who, as he tells it, asked one stupid question during a 1976 surgery: "Could you explain the physiology of erection to me?" The surgeon shrugged. Irwin spent the next decade figuring it out. Along the way, he co-discovered that nitric oxide, the elephant of our air, is what makes erections possible. He published the first paper on it in 1991. Seven years later, he became the first author on the New England Journal of Medicine paper that introduced Viagra to the world. But that's only half the story. The other half is Sue Goldstein, Irwin's college sweetheart turned partner in life, parenting, and eventually the practice itself. Sue spent decades raising their family while quietly absorbing the science her husband brought home. She is now an AASECT-certified educator, a published researcher, and one of the most outspoken patient advocates in the field. Together, they run San Diego Sexual Medicine, a clinic where every patient gets a three-hour visit, full education, and an entire team practicing what they call true bio-psycho social care. In this first half of our two-part conversation, Dr. Jenni Skyler and Daniel Lebowitz sit with the Goldsteins and explore how a field gets built, and how it still leaves so many patients behind. They cover prostate cancer and the silent erectile crisis that follows it. The buccal grafting innovation that's helping women with severe vestibular pain finally get answers. Why women, on average, see ten or twelve doctors before they get a real diagnosis. And Sue's pet peeve, medical gaslighting and what to do when a doctor says "there's nothing that can be done." This is a conversation for anyone who has ever felt unheard by a clinician, dismissed by their own body, or convinced they were the problem. The Goldsteins want you to know — you're not. You just haven't been to the right office yet. Irwin Goldstein, MD, IF (he/him/his)Director, San Diego Sexual Medicine5555 Reservoir Drive, Suite 300, San Diego, CA 92120Director, Sexual Medicine, UC San Diego Health East Campus, San Diego, CAClinical Professor of Urology, University of California at San DiegoVoluntary Clinical Professor of Obstetrics, Gynecology and Reproductive ServicesPast President, International Society for the Study of Women’s Sexual HealthPast President, Sexual Medicine Society of North AmericaEditor Emeritus, Sexual Medicine Reviews, The Journal of Sexual Medicine, International Journal of Impotence Researchphone: 619 265-8865fax: 619 265-7696mobile: 619 987-7432dr.irwingoldstein@gmail.comhttp://www.sandiegosexualmedicine.comLike us on Facebook: https://www.facebook.com/SDSexMedtwitter.com/SDSexualMedSee omnystudio.com/listener for privacy information.

Menopause is having a moment! After generations of misunderstanding, myths and mockery, menopause and perimenopause is starting to get the attention and support it deserves. And no wonder: in the United States, about 6,000 women enter menopause each day, according to scientific data. In this episode of NextAge Season 2, we're joining the conversation. You'll hear from some of familiar on-air hosts here at Nashville Public Radio about their experiences and medical experts who specialize in menopause healthcare.Got a story to share for our NextAge series? Leave us a message at 615-751-2500 or chime in during the live show on our YouTube stream.This season of NextAge is made possible by a grant from the West End Home Foundation — Advancing Aging with Dignity and Strengthening Communities — and by BlueCross BlueShield of Tennessee.This episode was hosted and produced by LaTonya Turner.Guests: Nina Cardona, Morning Edition Host, WPLN/Nashville Public Radio Jude Mason, Mid-day Host, WNXP Radio Leigh Mayo, Account Manager, WPLN/Nashville Public Radio Megan Jones, Digital Editor, WPLN/Nashville Public Radio Dr. William Lee, Associate Professor Obstetrics and Gynecology, Vanderbilt Medical Center; certified menopause practitioner  Anne-Ward Eshelman - Nurse Practitioner at HaneyGYN

High blood pressure disorders during pregnancy, including preeclampsia, can raise a lot of questions and anxiety for expectant parents. In this episode of The MotherToBaby Podcast, host Chris Stallman, genetic counselor, mom of four, and teratogen information specialist, sits down with maternal-fetal medicine specialist and member of the Society for Maternal-Fetal Medicine (SMFM) Dr. Karen Florio to discuss what pregnant women should know about hypertensive disorders in pregnancy and the role low dose aspirin can play in reducing certain risks. Dr. Florio shares both her professional expertise caring for high-risk pregnancies and her personal experience navigating a high-risk pregnancy herself. Together, Chris and Dr. Florio break down the warning signs of preeclampsia, when to contact a healthcare provider, and why low dose aspirin may be recommended in some pregnancies, even though regular aspirin is typically avoided during pregnancy. The conversation also explores how common hypertensive disorders are, what patients can do to advocate for themselves, and reassuring, evidence-based guidance for anyone currently pregnant and feeling worried about blood pressure concerns. In this episode, we discuss: • What "high blood pressure in pregnancy" and hypertensive disorders actually mean • Signs and symptoms of preeclampsia to watch for • Why low dose aspirin may be recommended during pregnancy • Who may benefit from low dose aspirin therapy • When to reach out to a healthcare provider • How patients can feel informed and empowered during pregnancy About Our Guest: Dr. Karen Florio is a maternal-fetal medicine specialist at the University of Missouri and currently serves as Vice Chair of Patient Safety and Quality for the Department of Obstetrics and Gynecology, as well as Director of Labor and Delivery. Her work focuses on hypertensive disorders of pregnancy and heart disease in pregnancy, and she has held leadership roles with Missouri's Pregnancy-Associated Mortality Review Board and the Missouri Perinatal Quality Collaborative. Learn more about MotherToBaby: https://mothertobaby.org/ Listen to more episodes of The MotherToBaby Podcast: https://mothertobaby.org/podcast/

Our guests this week are two accomplished sexuality professionals – Ms. Sue Goldstein and Dr. Irwin Goldstein. Ms. Sue Goldstein, a graduate of Brown University, is Sexuality Educator and Clinical Research Manager at San Diego Sexual Medicine (SDSM), responsible for sexual medicine educational programming and clinical research. She works with the SDSM team to develop clinical research projects, write protocols and oversee clinical trials. Ms. Goldstein co-authored When Sex Isn't Good to provide education and empowerment to women with sexual dysfunction. She is an associate editor of Textbook of Female Sexual Function and Dysfunction, and Female Sexual Pain Disorders, and author of multiple peer reviewed papers. Ms. Goldstein is past president of the International Society for the Study of Women's Sexual Health (ISSWSH). She served on committees in the International Society for Sexual Medicine (ISSM) and Sexual Medicine Society of North America (SMSNA). She is also a member of the American Association of Sex Educators, Counselors and Therapists (AASECT), the Association of Clinical Research Professionals (ACRP) and the International Society for Medical Shockwave Therapy. Ms. Goldstein, an ISSWSH Fellow, received the Distinguished Service Award from ISSWSH in 2017 as well as from SMSNA in 2017, and along with her husband, the Transformatory Team Award from ISSM in 2024. Dr. Irwin Goldstein has been involved with sexual dysfunction research since the late 1970s. He has authored more than 380 publications as well as multiple book chapters and edited 7 textbooks in the field. His interests include surgery for dyspareunia, sexual health management post cancer treatment, persistent genital arousal disorder/genital dysesthesia, physiologic investigation of sexual function, and diagnosis and treatment of sexual dysfunction in all genders. Dr. Goldstein is Director of Sexual Medicine at University of California San Diego East Campus, and sees patients in his private practice, San Diego Sexual Medicine. He is a Clinical Professor of Urology and Voluntary Clinical Professor of Obstetrics, Gynecology, & Reproductive Sciences at University of California San Diego. He is past Editor-in-Chief of the International Journal of Impotence Research, The Journal of Sexual Medicine, and Sexual Medicine Reviews. He is Past President of the International Society for the Study of Women's Sexual Health (ISSWSH) and the Sexual Medicine Society of North America (SMSNA). He holds a degree in engineering from Brown University and received his medical degree from McGill University. The World Association for Sexual Health awarded the Gold Medal to Dr. Goldstein in 2009 in recognition of his lifelong contributions to the field, in 2012 he received the ISSWSH Award for Distinguished Service in Women's Sexual Health, in 2013 he received the Lifetime Achievement Award from the SMSNA, and in 2014 he received the Lifetime Achievement Award from the International Society for Sexual Medicine (ISSM). He is happily married to his college sweetheart Sue, and together they have three children and five grandchildren. Sue and Irwin Goldstein have been titans in the field of sexology for some time now; they were there on May 14, 1998 when the first article on sildenafil (Viagra) was published with Irwin Goldstein as the first author. Listeners, if you would like to reach out to Ms. Sue Goldstein and/or Dr. Irwin Goldstein, check out the San Diego Sexual Medicine website! If you want to catch up on other shows, just visit our website and please subscribe! We love our listeners and welcome your feedback, so if you love Our Better Half, please give us a 5-star rating and follow us on Facebook and Instagram. It really helps support our show! As always, thanks for listening!  

Hyperemesis gravidarum (HG) represents the most severe end of the nausea and vomiting of pregnancy spectrum. It has a reported incidence of approximately 0.3–3% of pregnancies and is the most common cause of hospitalization in early pregnancy and the second most common cause of hospitalization in pregnancy overall. In June 2024, the ACOG published a Clinical Expert series summarizing the inpatient management of HG. In that guidance, it describes mirtazapine as an “alternative pharmacologic” option. How effective is this medication compared to ondansetron? A new study (published ahead of print on 12/30/25 and officially out June 2026), out of Denmark, sheds some new light on this medication. This trial is the first double-blind RCT comparing mirtazapine to ondansetron AND placebo. Although a BIG limitation of this study exists (which we will discuss), it does provide some interesting insights. Listen in for details.1. (ACOG CES) Clark, Shannon M. MD; Zhang, Xue MD; Goncharov, Daphne Arena MD. Inpatient Management of Hyperemesis Gravidarum. Obstetrics & Gynecology 143(6):p 745-758, June 2024. | DOI: 10.1097/AOG.00000000000055182. Ostenfeld, AnneDroogh, Marjoes et al.Mirtazapine or ondansetron for hyperemesis gravidarum. A randomized placebo-controlled trial. American Journal of Obstetrics & Gynecology, June 2026

Two articles in CMAJ look at endometriosis from sharply different angles. One shows how devastating delayed recognition can be, following a patient whose deep infiltrating endometriosis led to renal atrophy, bowel obstruction, sciatic nerve impingement and a permanent ostomy. The other offers a more reassuring picture, finding only a small increased risk of congenital anomalies among infants born to patients with endometriosis. Together, they show why endometriosis deserves earlier recognition, better imaging and more serious clinical attention.Dr. Sony Singh, chair of the Department of Obstetrics and Gynecology at the University of Ottawa and head of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital, discusses the CMAJ practice article, “Renal atrophy, bowel obstruction, and sciatic nerve impingement secondary to endometriosis”. He explains how deep infiltrating endometriosis can invade adjacent organs and cause severe fibrosis when left untreated.Bailey Milne, a PhD candidate in epidemiology at Queen's University, discusses the CMAJ article, Risk of congenital anomalies for infants born to patients with endometriosis: a population-based cohort study. She emphasizes that although the study found a small increased risk of congenital anomalies, the overall risk remains low.For physicians, the episode highlights the importance of considering endometriosis in patients with cyclical pelvic, abdominal, bowel, urinary or sexual pain, even when initial imaging is normal.For more information from our sponsor, go to md.ca/lifeplanComments or questions? Text us.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X  @BlairBigham and @DrmojolaomoleX (in English):  @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Cervical exams can be tricky for the novice practitioner. Think about this: it's a blind exam, we measure that distance using only two fingers, through a layer of tissue, sometimes with a patient moving up on the bed as we examine. That is the reality of a cervical exam. Intrapartum, some nursing staff and clinicians use qualitative descriptors like "a tight 4" or "a generous 5" to convey nuance. In line with this, some report cervical examinations in “half- centimeters”. This sounds like this: “well, her last cervical exam was 5cm but now she is 5 and a half”. Is that a thing? What does the data say? Listen in for details. 1. Hamilton EF, Zhoroev T, Warrick PA, et al. New Labor Curves of Dilation and Station to Improve the Accuracy of Predicting Labor Progress. American Journal of Obstetrics and Gynecology. 2024. 2. Hanidu A, Kovalenko M, Usman S, et al. Intrapartum Ultrasound for Cervical Dilatation: Inter- And Intra-Observer Agreement. Acta Obstetricia Et Gynecologica Scandinavica. 2024. 3. Abedi, P. (n.d.). Accuracy of ultrasound methods versus other methods for detecting of cervical dilatation during labor, a protocol for systematic review. ECronicon.

Editor's Choice:  Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleedingEditorial: Tampon-based methylated DNA testing for endometrial cancer: Promising innovation, but prudence before practiceHosted by: Charles N. Landen Jr., MD; University of Virginia Charlottesville, VA, USAFeaturing: Jamie N. Bakkum-Gamez, MD; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USAJohn B. Kisiel, MD; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USAJoy M. Davis MD; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USACheck out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

As I have said many times before, some podcast ideas come from REAL clinic encounters. In this episode, Dr Hanna V, our dedicated PGY1 on our call team, and I will answer TWO real questions which arose just today on morning rounds, on our service: 1. Does NORMOTENSIVE HELLP still need Mag Sulfate? And 2. Does an indwelling foley s/p iatrogenic bladder injury at CS require prophylactic antibiotic coverage for urinary infection? Yep: It's a BOGO sale on today's podcast- Buy ONE GET ONE! Listen in for details.1. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.Obstetrics and Gynecology. 2020. Committee on Practice Bulletins—ObstetricsGuideline2. Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T.SR. Corticosteroids for HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelets) Syndrome in Pregnancy.The Cochrane Database of Systematic Reviews. 2010. 3. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA.Liver Disease in Pregnancy. Lancet. 2010. Review4. Rimaitis K, Grauslyte L, Zavackiene A, et al.Observational. Diagnosis of HELLP Syndrome: A 10-Year Survey in a Perinatology Centre. International Journal of Environmental Research and Public Health. 20195. Reau N, Munoz SJ, Schiano T.Guideline Liver Disease During Pregnancy.The American Journal of Gastroenterology. 2022. 6. ACG Clinical Guideline: Liver Disease and Pregnancy.The American Journal of Gastroenterology. 2016. Tran TT, Ahn J, Reau NS.7. ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures. Obstetrics and Gynecology. 2018. Committee on Practice Bulletins—Gynecology Guideline8. Niels Johnsen, Hunter Wessells, Krystal Archer-Arroyo, et al. Best Practices Guidelines Management of Gentiunrinary Injuries.American College of Surgeons (2025). 20259. Fletke KJ, Jeong DH, Herrera AV . Urinary Catheter Management. American Family Physician. 2024..

One overlooked element of long-term success is proactive health planning, including fertility. Many people set goals for career, finances, and fitness, but rarely set goals for reproductive health until it becomes urgent. So why is fertility planning a success strategy, and what steps can you take RIGHT NOW to protect your fertility?  Dr. Jeanine Cook-Garard and Pandora Groth talk with Dr. Oluyemisi Famuyiwa, a National Institutes of Health–trained reproductive endocrinologist, and the author of The Quest for Fertility. She is also an Assistant Professor of Obstetrics and Gynecology at George Washington University, and host of the Fertile Talks podcast.

Hantavirus was first discovered in the early 1950s near the Hantaan River in South Korea. The US has seen this before: the 1993 Four Corners outbreak was the first recognition of the virus in the United States, causing a deadly respiratory syndrome. Now, Hantavirus is in the news again with 17 Americans currently (5.10.26) enroute back to the US for specialized observation. In this episode, we will briefly review what this virus does and cover the SPARSE data we have regarding hantavirus infection in pregnancy. 1. Gilson GJ, Maciulla JA, Nevils BG, et al. Hantavirus Pulmonary Syndrome Complicating Pregnancy. American Journal of Obstetrics and Gynecology. 1994. 2. 5.10.26: https://www.nbcnews.com/health/health-news/hantavirus-stricken-cruise-ship-arrives-tenerife-rcna3443183. Janwadkar RS, Ritchie HM, Johnson CA. Unexpected Challenges: A Case Report of Hantavirus Infection in a Pregnant Patient in a Rural Emergency Department. The Journal of Emergency Medicine. 2025.

The postpartum period can be one of the most vulnerable and challenging times in a parent’s life. It's also one of the least talked about. That's despite mental health disorders being the leading complication of childbirth in the United States of America, affecting 1 in 5 women. The postpartum period can bring depression, anxiety and a host of other mental health challenges. And too often, parents are left wondering what’s normal and where to turn for help. This hour, we explore postpartum mental health and what support is available in Connecticut. We’re joined by a doctor from St. Mary's Hospital, where a new unit, designed specifically for pregnant and postpartum patients, recently opened. We also hear from Postpartum Support International’s Connecticut chapter about why this period is so high-risk and how they’re working to connect families with care. And later, we’ll hear one mother’s story of navigating postpartum depression, and how she’s processed that experience through a new collection of poetry. Guests: Kassondra Mangione, author of "Coffee Mug Rings" Dr. Irina Magidina, chair of Obstetrics and Gynecology at Saint Mary’s Hospital Jennifer Vendetti, co-chair, Board of Directors, Postpartum Support International Connecticut Chapter Samantha Smalls, Board of Directors, Postpartum Support International Connecticut Chapter Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

When Kemi Doll was in medical school, she learned that Black women are twice as likely to die from uterine cancer as white women, and also suffer disproportionately from other uterine-related conditions. What wasn't explained was why. Now a gynecologic oncologist, Doll has made it her mission to change these trends and improve care for Black women.  She joins Flora to discuss her new book, “A Terrible Strength: The Hidden Crisis of the Black Womb and Your Survival Guide to Healing.” They explore the way systemic racism and the normalization of Black women's pain lead to later diagnoses of uterine cancer and poorer health outcomes for a range of gynecologic conditions including fibroids, endometriosis, and heavy periods. And Doll explains the problem with using reproductive health as a synonym for uterine health.  Guest:  Dr. Kemi Doll is a gynecologic oncologist and professor at the University of Washington Schools of Medicine and Public Health.  Other episodes you may enjoy: Endometriosis Is Common. Why Is Getting Diagnosed So Hard? A Black Physician's Analysis Of The Legacy Of Racism In Medicine Want SciFri gear? Check out our new shop! Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-4-SCIFRI

Dr. Thomas Jansson, the 2026 winner of the March of Dimes Agnes Higgins Award in Maternal-Fetal Nutrition, the Vice Chair of Research for the University of Colorado Anschutz Department of Obstetrics and Gynecology and the department's Florence Crozier Cobb Endowed Professor and Chief of the Division of Reproductive Sciences, discusses his research showing that contrary to popular belief, it is not the fetus, but a placental protein signaling hub called mTOR, that is the primary architect of fetal growth.

In 2024 Novo Nordisk announced it would discontinue Levimir insulin.. leaving many people scrambling and kind of stunned. There's no other insulin on the market quite like this long-acting – and it turns out the community wasn't letting it go without a fight. My guests are going to tell you more about why. I'm taking to Alison Smart, founder of The Alliance to Protect Insulin Choice – her daughter lives with type 1 as well as two doctors: Florence Brown and Amy Valent. Dr. Brown is Co-Director Joslin and BIDMC Diabetes in Pregnancy Program, Assistant Professor of Medicine, Harvard Medical School. Dr. Valent Assistant Professor of Obstetrics and Gynecology, School of Medicine at Oregon Health and Science University. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

Academic medicine affects patient care in important ways. Julia Cormano, M.D., F.A.C.O.G., Assistant Dean for Clinical Curriculum, Associate Professor of Obstetrics, Gynecology, & Reproductive Sciences, UC San Diego, explains how medical students, resident physicians, and fellows contribute to care in a supervised teaching hospital environment. Cormano defines the role of each learner, outlines how they participate in hospitals and clinics, and shows how team-based care can bring more attention, more listening, and up-to-date medical knowledge to each patient's case. She also explains that attending physicians oversee every decision, combining experienced judgment with the energy and perspective of learners. This work helps clarify how academic medicine supports both patient care and physician training and points toward a broader understanding of why teaching hospitals play an important role in healthcare. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41180]

Academic medicine affects patient care in important ways. Julia Cormano, M.D., F.A.C.O.G., Assistant Dean for Clinical Curriculum, Associate Professor of Obstetrics, Gynecology, & Reproductive Sciences, UC San Diego, explains how medical students, resident physicians, and fellows contribute to care in a supervised teaching hospital environment. Cormano defines the role of each learner, outlines how they participate in hospitals and clinics, and shows how team-based care can bring more attention, more listening, and up-to-date medical knowledge to each patient's case. She also explains that attending physicians oversee every decision, combining experienced judgment with the energy and perspective of learners. This work helps clarify how academic medicine supports both patient care and physician training and points toward a broader understanding of why teaching hospitals play an important role in healthcare. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41180]

Academic medicine affects patient care in important ways. Julia Cormano, M.D., F.A.C.O.G., Assistant Dean for Clinical Curriculum, Associate Professor of Obstetrics, Gynecology, & Reproductive Sciences, UC San Diego, explains how medical students, resident physicians, and fellows contribute to care in a supervised teaching hospital environment. Cormano defines the role of each learner, outlines how they participate in hospitals and clinics, and shows how team-based care can bring more attention, more listening, and up-to-date medical knowledge to each patient's case. She also explains that attending physicians oversee every decision, combining experienced judgment with the energy and perspective of learners. This work helps clarify how academic medicine supports both patient care and physician training and points toward a broader understanding of why teaching hospitals play an important role in healthcare. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41180]

The ACOG recommends a multimodal approach to postoperative pain that includes nonsteroidal NSAIDs, acetaminophen, and opioids. Ketorolac is a favored NSAID for postop pain control. However, the optimal dose of ketorolac after cesarean delivery has not been determined. In this episode, we will summarize a brand new randomized, controlled, single-blind trial of pregnant women undergoing cesarean delivery under regional anesthesia at a large academic medical center between June 2022 and October 2023. Enrolled participants were randomized to receive an initial loading dose of 60 mg (intervention) or 30 mg (control) of intravenous ketorolac in the operating room at the end of surgery.1. Pharmacologic Stepwise Multimodal Approach for Postpartum Pain Management: ACOG Clinical Consensus No. 1. Obstetrics and Gynecology. 2021.2. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics and Gynecology. 2020.3. Eid, Joe MD; Caplan, Madeleine MD; Goel, Nidhi MD; Poirier, Marie-Veronique MD; Montaine-O'Brien, Skyler MS; Rood, Kara M. MD; Costantine, Maged M. MD. Two Perioperative Ketorolac Dosing Regimens After Cesarean Delivery and Opioid Use: A Randomized Controlled Trial. O&G Open 3(2):e159, April 2026. | DOI: 10.1097/og9.0000000000000159

Uterine hemorrhage remains a significant complication following abortion loss and in the postpartum period and contributes to substantial morbidity and mortality among pregnant patients. Although some FDA approved devices are on the market (Bakri balloon and Jada vacuum), they may be cost prohibited in some settings and/or some uterine cavities may be very small for either option, like after a mid-second trimester or early third trimester PPH. But every delivery unit has some form of suction tool and wall suction ability. This is where FOCUS*, STUT, and/or U-CaVIT come into play. And now there is new data on this from the AJOG (epub, April 2026). Listen in for details. (*Shout Out to Dr. Frank Jackson for his work on this as well).1. Singata-Madliki et al. Suction Tube Uterine Tamponade Versus Uterine Balloon Tamponade for Treatment of Refractory Postpartum Hemorrhage: A Randomized Clinical Feasibility Trial. International Journal of Gynaecology and Obstetrics: The Official Organ of FIGO. July 2025. (South Africa)2. Hofmeyr GJ, Singata-Madliki M. Novel Suction Tube Uterine Tamponade for Treating Intractable Postpartum Haemorrhage: Description of Technique and Report of Three Cases. BJOG : An International Journal of Obstetrics and Gynaecology. 20203. Jackson FI, Dilena NJ, Abelman SH, Blitz MJ, Gerber S. Hemorrhage management using a Foley catheter for uterine suction. Am J Obstet Gynecol. 2025 Nov;233(5):503-504. 4. ACOG Practice Bulletin No. 183: Postpartum Hemorrhage. Obstetrics and Gynecology. 2017. 5. Ranieri E, Kalimeris S, Ochsenbein N, Haslinger C, Vacuum-Induced Tamponade Using Urological Catheters for Postpartum Hemorrhage, American Journal of Obstetrics and Gynecology (2026), doi: https://doi.org/10.1016/j.ajog.2026.04.026

In this episode of Dismantling You, I sit down with Dr. Randi Goldman, a fertility specialist, to have an honest conversation about what the fertility world actually looks like today. We dig into the realities of IVF success rates, why one cycle does not equal one baby, and how age remains the single most important factor in fertility outcomes. Dr. Goldman shares what she wishes more patients knew before walking through her doors, from the importance of early education to the limitations of egg freezing as a backup plan.We also explore endometriosis and its often silent impact on fertility, the difference between ovarian reserve and egg quality, and why so many people are caught off guard by their own biology. Dr. Goldman breaks down the role of lifestyle factors like nutrition, sleep, stress, and environmental toxins, and explains what patients can actually control in a process that often feels completely out of their hands. This is one of those conversations that cuts through the noise and gives you clarity you can act on.__________________________________________________Key Highlights

Send us Fan MailMenopause is a natural part of aging, yet it remains one of the most scary and misunderstood stages of a woman's life. For this episode, our guest expert helps us separate fact from fiction regarding this transition. David Rogers, M.D., an OB/GYN with Texas Tech Physicians and associate professor and vice chairman of the Department of Obstetrics and Gynecology in the TTUHSC School of Medicine, joins us to talk about the basics of menopause — what is actually happening in the body during this shift, the common symptoms to look out for, and the truth behind some of the most persistent myths. Dr. Rogers also provides insights into how women can manage their health during this phase and how to advocate for themselves.

Dr. Denise Schumacher is a board-certified physician who specializes in Gynecology, covering the full spectrum of women’s health. A deep dive into the medications on the market for menopause! See omnystudio.com/listener for privacy information.

Fertility is a powerful reflection of your overall health—not a separate or isolated system. In this episode, fertility expert Dr. Natalie Crawford breaks down what's really happening physiologically as fertility shifts in midlife, connecting the dots between hormones, metabolism, inflammation, and egg quality.  We dive into the everyday habits quietly disrupting fertility—from chronic stress and blood sugar imbalances to inflammation—and how these factors directly impact ovulation and hormone signaling.  Dr. Crawford also cuts through the noise around age, offering a more nuanced, science-backed perspective on what you can actually do to support your fertility at any stage.  You'll learn that it's the simple shifts each month that can make a meaningful difference starting now.  Ready to support your body from the inside out? Tune in here! Natalie Crawford, MD  Dr. Natalie Crawford is board-certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility and is co-founder of Fora Fertility, a boutique fertility practice in Texas. She's the CEO and co-founder of Pinnacle, a professional network for women in medicine. Dr. Crawford is a digital health educator on social media and hosts the podcast  “As a Woman” with over 6 million downloads. Her new book, “The Fertility Formula”, will be released this spring.  IN THIS EPISODE How is fertility a reflection of your body's overall environment?  Accurate cycle tracking and what signals to pay attention to  Factors that disrupt fertility and how to catch issues early on  How inflammation and metabolic health are deeply tied to fertility  5 non-negotiables when it comes to women's health and wellness High-impact changes to help support your fertility  Fertility recommendations for women 35 and older  Dr. Crawford's fertility story and how to get her new book, The Fertility Formula QUOTES“The follicular phase and luteal phase are the two phases of the cycle, and learning to track your ovulation specifically is a really important tool because the early stages of ovulatory dysfunction all occur within a normal cycle, meaning the first stage is a short luteal defect.” “I can't control everything, but I want to control what I can, so I have the easiest time getting pregnant, I feel my best, I have the best odds of success if I have to do fertility treatments. That's the zone we want to live in, and we want to lower that inflammatory burden on the day-to-day, not to be all or nothing, but to really cultivate that body resilience so we can handle the challenges of life that we know are coming.” “It's your body's data. You're gonna find out one way or another, and I think you deserve to know it sooner.” RESOURCES MENTIONED Order my new book: The Perimenopause Revolution HERE! https://peri-revolution.com/ Pre-order The Fertility Formula https://www.nataliecrawfordmd.com/book Dr. Natalie Crawford on socials:  Instagram TikTok YouTube Dr. Crawford's Podcast: As A Woman RELATED EPISODES  691: The Fertility Crisis No One Talks About: Why Your Health Today Impacts Future Generations with Dr. Ann Shippy 530: The Critical Role That Nutrient Deficiencies Play In Fertility and Conception And How To Close The Gap with Lisa Dreher 687: The Period Brain: Why You Feel Like a Different Person Every Month And How To Stop Fighting Your Cycle and Start Thriving in It with Sarah Hill 735: The Stress–Metabolism Connection: Why You're Gaining Weight, Craving Sugar & Struggling with Energy

Natalie Crawford, MD is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility and is co-founder of Fora Fertility, a boutique fertility practice in Austin, Texas. Dr. Crawford is CEO and co-founder of Pinnacle, a professional network for women in medicine. She completed her undergraduate at Auburn University obtaining a degree in Nutrition Science, Medical School at UTMB, OBGYN Residency at UTSW, and REI Fellowship at UNC, concurrently obtaining a Master of Science in Clinical Research. Dr. Crawford is a digital health educator on social media, YouTube, and hosts the podcast  “As a Woman” with over 6 million downloads. Her debut book, “The Fertility Formula”, will be released by Penguin Random House.   Follow Dr. Crawford on Instagram at @nataliecrawfordmd and check out her book, The Fertility Formula.   Related Episodes: Ep 155 - Dr. Marguerite Duane on FACTS about Fertility Ep 314 - The Fertility Crisis + Support for Couples with Ronit Menashe + Vida Delrahim   If you like this episode, please subscribe to Pursuing Health on iTunes and give it a rating or share your feedback on social media using the hashtag #PursuingHealth. I look forward to bringing you future episodes with inspiring individuals and ideas about health.   Disclaimer: This podcast is for general information only, and does not provide medical advice.  I recommend that you seek assistance from your personal physician for any health conditions or concerns.

Momentum for homeopathy continues to grow, and Gabrielle Traub returns to share the encouraging developments she's been part of. A board-certified classical homeopath and international bestselling author, Gabrielle discusses her conversations with leading doctors and researchers, as well as the growing curiosity surrounding homeopathy. We explore her background in clinical research, her work in women's health alongside conventional OB-GYN practices, and her founding of World Homeopathy Awareness Week, now recognized in 46 countries. She also shares her recent participation in high-level policy discussions and advocacy efforts. Throughout the episode, Gabrielle highlights the importance of raising awareness and supporting homeopathy's place in healthcare. Episode Highlights: 09:35 - Gabrielle's Involvement with RFK Jr. and Advocacy Groups 12:54 - Collaborative Efforts in Homeopathy Research 17:21 - Being “the homeopath in the room” 21:24 - Why visibility of research matters 25:15 - The global spirit of World Homeopathy Awareness Week 28:45 - Patient stories matter most 32:18 - Why sharing matters 33:47 - A movement rooted in health freedom 35:28 - Gabrielle's Books and Resources 40:49 - Call to Action for Community Support About my Guests: Gabrielle Traub is a board-certified classical homeopath and international best-selling author whose journey into homeopathy began in early childhood after the tragic loss of her brother at age two due to a fatal drug reaction. Years later, when her surviving brother experienced a life-threatening anaphylactic reaction to an antibiotic and required resuscitation, her parents sought a safer approach to healing and discovered homeopathy. This experience inspired Gabrielle's lifelong passion for healing. She later earned a five-year homeopathic medical degree in South Africa and went on to conduct double-blind randomized controlled trials investigating homeopathic treatment for ADHD and anxiety. Gabrielle is the author of Live Right For Your Remedy Type, a homeopathic lifestyle guide that emphasizes individualized health and prevention. She has lectured and taught internationally in England, South Africa, Pakistan, Dubai, Israel, Australia, and across the United States. Her clinical focus includes women's health, where she spent over a decade working within a conventional OB-GYN practice alongside a traditional obstetrician and fertility endocrinologist. During this time, she observed a significant rise in infertility and gynecological disorders, which led her to co-author (In) Fertility: Secrets, Struggles, and Successes and develop one of the most comprehensive courses on homeopathic treatment of Obstetrics and Gynecology. Her broader clinical experience also includes serving on a core treatment team at an inpatient center specializing in addiction, PTSD, chronic pain, and eating disorders. Gabrielle is featured in the documentary Introducing Homeopathy, founded World Homeopathy Awareness Week celebrated in 46 countries, formerly served as chair of the World Homeopathy Awareness Organization, and currently serves as External Affairs Advisor for Americans for Homeopathy Choice and spokesperson within the MAHA community. In recent years, Gabrielle has expanded her work into national policy and advocacy. She was invited by the MAHA Institute to speak at multiple high-level roundtables and met with Jay Bhattacharya, which led to discussions with the National Center for Complementary and Integrative Health (NCCIH) about updating their public statement on homeopathy and exploring research opportunities. She coordinated presentations on homeopathic research for NCCIH leadership, engaged in discussions regarding homeopathy's role in epidemic settings, and built relationships with leaders within the U.S. Department of Health and Human Services. Gabrielle has helped build support for the homeopathy bill H.R. 7050, contributed articles to The MAHA Report and The Epoch Times, coordinated collaboration between major homeopathic organizations, and participated in high-level events including the MAHA Inaugural Ball, the HHS Women's Health Conference, and an exclusive gathering at the NED Club. She also comes from a distinguished lineage of advocacy and leadership—her father was honored by Nelson Mandela for legal reforms in South Africa, her grandfather served as a long-standing mayor, and her grandmother devoted her life to humanitarian work, earning a personal visit and award from Queen Elizabeth II. World Homeopathy Awareness Week (WHAW) Information https://homeopathycenter.org/world-homeopathy-awareness-week/ WHAW 2026 Events https://homeopathycenter.org/whaw-2026-events/ Gabrielle's Website https://www.sandiegohomeopathy.com Gabrielle's Books https://homeopathicbook.com Introducing Homeopathy & Investigating Homeopathy https://introducinghomeopathy.com/ Homeopathic Research Institute https://www.hri-research.org/ Homeopathic Research Institute — Research Databases https://www.hri-research.org/resources/research-databases/ American Institute for Homeopathy — Research Guide https://homeopathyusa.org/aih-guide-to-homeopathic-research/ Americans for Homeopathy Choice — Research https://homeopathychoice.org/research/ NCH Quotable Homeopathy Research Library https://homeopathycenter.org/research/ Evidence-Based Homeopathic Family Medicine (eBook) — Dana Ullman https://homeopathic.com/evidence-based-homeopathic-family-medicine-sample-191-pages-of-the-750-page-ebook/ Support the Homeopathy Bill & Advocacy https://homeopathychoice.org/ Facebook Group — Live Right For Your Remedy Type https://www.facebook.com/groups/liverightforyourremedytype Instagram https://www.instagram.com/traubgabrielle/ If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode. Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/ Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom            

Welcome to Fertility & Sterility Roundtable, hosted by Dr. Emily Barnard and Dr. Ben Peipert! Each week, we will host a discussion with the authors of "Views and Reviews" and "Fertile Battle" articles published in a recent issue of Fertility & Sterility.  Today, we will be discussing a challenge that all of us in the field of reproductive medicine face, ovarian aging. We will specifically be discussing the Views and Reviews article from the March 2026 edition of Fertility and Sterility entitled "Influencing ovarian aging in reproductive medicine: promise, evidence, and unresolved questions." We are joined by three of the esteemed authors of this publication to dive into this topic, learn about new research, and sort out what treatments are and are not yet ready for prime time use in clinical practice.  Dr. Kara Goldman is a reproductive endocrinologist and Associate Professor of Obstetrics and Gynecology at Northwestern University, where she serves as Director of Fertility Preservation. Dr. Goldman leads a high-volume clinical program in complex fertility preservation, and her translational research focuses on the role of mTOR signaling in ovarian aging and strategies to preserve ovarian function during cancer treatment and physiologic aging. Her work led to several landmark publications and Prize Paper Awards from the American Society for Reproductive Medicine; she also serves on the editorial board of Fertility and Sterility. Dr. Francesca Duncan is an Associate Professor of Obstetrics and Gynecology at the Feinberg School of Medicine at Northwestern University. She co-directs Northwestern's Center for Reproductive Science and leads a research program focused on the cellular mechanisms of reproductive aging, studying how aging affects reproductive potential at the level of the egg and ovary. Over her career, she has co-authored numerous, and her research has been widely featured in several major news outlets including National Geographic, the New York Times, and the Wall Street Journal.  Dr. Allison Eubanks is a REI fellow in the NIH–Walter Reed training program and currently serves as the Fertility and Sterility Editorial Board Fellow. She is an active-duty U.S. Navy physician. Her work spans research across all aspects of reproductive endocrinology and infertility from ART to menopause, along with education and policy initiatives aimed at improving women's health and reproductive care across the military health system.   Read the Fertile Battle from Volume 125, Issue 3 p387-398 in the March 2026 issue View Fertility and Sterility at https://www.fertstert.org/

The diagnosis of fetal growth restriction can be made with an isolated abdominal circumference less than the 90th percentile. So is the opposite true? Does a fetal abdominal circumference (isolated) of greater than 90% qualify for “LGA” fetus? In this episode we're going to explain why, although it is logically correct, it is diagnostically incorrect. An isolated abdominal circumference on ultrasound of greater than 90% is however a strong predictive risk factor for one delivery finding. Listen in for details.1. Macrosomia: ACOG Practice Bulletin, Number 216. Obstetrics and Gynecology. 20202. Canavan TP, Hill LM.. Sonographic Biometry in the Early Third Trimester: A Comparison of Parameters to Predict Macrosomia at Birth. Journal of Clinical Ultrasound : JCU. 2015. 3. Culliney KA, Parry GK, Brown J, Crowther CA. Regimens of Fetal Surveillance of Suspected Large-for-Gestational-Age Fetuses for Improving Health Outcomes.The Cochrane Database of Systematic Reviews. 2016.

I'm thrilled to connect with Dr. Natalie Crawford today. She's a double-board-certified fertility doctor and the author of The Fertility Formula. Unlike most other physicians, she blends lifestyle and functional medicine with science-based facts, aiming to help women conceive and understand their bodies. While this conversation may not feel fully aligned with the perimenopause and menopause transition, I encourage you to listen with an open mind to what Natalie shares about hormones. In our discussion, we explore fertility as a vital sign, the impact of infertility, and why one in six women experiences infertility. We break down ovarian reserve and the realities of aging. We also cover specific labs that can help assess ovarian reserve and overall health. We explain DOR and POI, the overlap between fertility and perimenopause, and why the ovaries can behave like a “cranky toddler” in perimenopause. Finally, we dive into the role of the gut microbiome in estrogen metabolism and inflammation, and discuss IVF, egg freezing, modern reproductive options, lifestyle influences, and a series of rapid-fire questions. Dr. Crawford's book, The Fertility Formula, is a must-read for women of all ages. It contains many valuable insights, and I love the way she blends an integrative approach with an allopathic approach for her patients. IN THIS EPISODE, YOU WILL LEARN: How fertility serves as a health marker that reflects a woman's hormonal, cellular, and metabolic health The role of inflammation in infertility Dr. Crawford clarifies ovarian reserve, highlighting the importance of understanding egg quality and quantity. Why AMH testing is the most informative first step for women concerned about their fertility Dr. Crawford outlines three factors that can cause missed or irregular periods. The importance of tracking ovulation and understanding the body's signals during perimenopause Inflammation and aging can disrupt chromosome alignment and impair embryo development. How poor estrogen clearance and gut microbiome imbalances disrupt brain-ovary signaling and ovulation timing The link between sleep deprivation and low sperm counts, and how stress and lack of muscle mass can drive insulin resistance and inflammation Why sleep, muscle mass, and stress reduction are all essential for fertility It's essential to approach fertility proactively, and to know how to do that. Bio: Natalie Crawford Natalie Crawford, MD, is board-certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility and is co-founder of Fora Fertility, a boutique fertility practice in Austin, Texas. Dr. Crawford is CEO and co-founder of Pinnacle, a professional network for women in medicine. She completed her undergraduate degree at Auburn University, obtaining a degree in Nutrition Science, Medical School at UTMB, OBGYN Residency at UTSW, and REI Fellowship at UNC, concurrently obtaining a Master of Science in Clinical Research. Dr. Crawford is a digital health educator on social media, YouTube, and hosts the podcast  “As a Woman” with over 6 million downloads. Her debut book, “The Fertility Formula”, will be released by Penguin Random House.  Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow. Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Natalie Crawford On her website On social media: @NatalieCrawfordMD Dr. Crawford's book, The Fertility Formula, is available here.

Today we're diving into a topic that so many women experience but far too few of us are adequately prepared for—perimenopause. My guest is Dr. Mary Claire Haver, a board-certified OB-GYN, Certified Menopause Practitioner, and New York Times bestselling author of The New Menopause and her most recent book, The New Perimenopause. Through her clinical work, her online programs like The Galveston Diet, and her platform The 'Pause Life, Dr. Haver has become a leading voice in making menopause education accessible, practical, and grounded in science. In our conversation, we explore the biological and emotional complexities of perimenopause, why early intervention—including hormone therapy—can be so important, and the gaps in medical training that have left many women feeling dismissed or unprepared. Dr. Haver shares practical strategies for managing symptoms, explains what she calls “The Menopause Toolkit,” and offers empowering guidance to help women advocate for their health and navigate this transformative phase with more knowledge, confidence, and support.  About Dr. Mary Claire Haver  Dr. Mary Claire Haver, MD, FACOG, CMP, is a board-certified Obstetrics and Gynecology specialist, a Certified Menopause Practitioner from The Menopause Society (formerly the North American Menopause Society (NAMS)), an Adjunct Associate Professor at University of Texas Medical Branch (UTMB), a Certified Culinary Medicine Specialist, and a passionate entrepreneur and best-selling author with a focus on women's health. Dr. Haver graduated from Louisiana State University Medical Center and completed her Obstetrics and Gynecology residency at UTMB.  As her patient population grew older, Dr. Haver started receiving numerous complaints and concerns about weight gain during menopause. This inspired her to do a deep dive into the science of menopause, aging, and inflammation beyond what she was taught in school and residency, which led to the creation of The Galveston Diet online program and, in 2023, a national bestselling book. Dr. Haver integrates a patient's medical history, symptomatology, nutrition, exercise, supplements, and possibly hormone therapy, or what she likes to call "The Menopause Toolkit."  Dr. Haver has a large social media following of over 7 million, where she posts advice for menopausal women and learns a great deal from her followers and community. She aims to make menopause care easy and accessible for everyone. She founded The 'Pause Life, a comprehensive approach to menopause education and support, and is the author of the New York Times bestseller, The New Menopause and her most recent title The New Perimenopause.  Things you'll learn from this episode  What differences there are between the biological process of perimenopause and menopause The impact of hormone shifts in estrogen, progesterone, and testosterone on women's mental health and brain fog during perimenopause Ways to effectively communicate with healthcare providers who may not be up to speed on menopause research and/or may be dismissive of symptoms The benefits and timing of menopause hormone therapy during perimenopause Resources mentioned The Pause Life (Mary Claire's website and online community) The New Perimenopause: An Evidence-Based Guide to Surviving the Zone of Chaos and Feeling Like Yourself Again by Dr. Mary Claire Haver The New Menopause: Navigating Your Path Through Hormonal Change with Purpose, Power, and Facts by Dr. Mary Claire Haver UnPaused Podcast Dr. Mary Claire Haver on Instagram Dr. Mary Claire Haver on YouTube Dr. Mary Claire Haver on Facebook Learn more about your ad choices. Visit podcastchoices.com/adchoices

In episode #433 of The Hormone Puzzle Podcast, our guest, Dr. Natalie Crawford, MD, talks about The Truth About the Biological Clock and Egg Quality – Why Fertility Is About More Than Just Age. More about Dr. Natalie Crawford: Natalie Crawford, MD is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility and is co-founder of Fora Fertility, a boutique fertility practice in Austin, Texas. Dr. Crawford is CEO and co-founder of Pinnacle, a professional network for women in medicine. She completed her undergraduate at Auburn University obtaining a degree in Nutrition Science, Medical School at UTMB, OBGYN Residency at UTSW, and REI Fellowship at UNC, concurrently obtaining a Master of Science in Clinical Research. Dr. Crawford is a digital health educator on social media, YouTube, and hosts the podcast  "As a Woman" with over 6 million downloads. Her debut book, "The Fertility Formula", will be released by Penguin Random House. Thank you for listening! This episode is brought to you in partnership with Proov - https://proovtest.com/PUZZLE Follow Dr. Natalie on Instagram: @‌nataliecrawfordmd Check out her latest book, "The Fertility Formula" here: nataliecrawfordmd.com/book Pre-order the book "The Fertility Formula" on Amazon. Follow Dr. Kela on Instagram: @‌kela_healthcoach Get your FREE Fertility Meal Plan: https://hormonepuzzlesociety.com/ FTC Affiliate Disclaimer: The disclosure that follows is intended to fully comply with the Federal Trade Commission's policy of the United States that requires to be transparent about any and all affiliate relations the Company may have on this show. You should assume that some of the product mentions and discount codes given are "affiliate links", a link with a special tracking code This means that if you use one of these codes and purchase the item, the Company may receive an affiliate commission. This is a legitimate way to monetize and pay for the operation of the Website, podcast, and operations and the Company gladly reveals its affiliate relationships to you. The price of the item is the same whether it is an affiliate link or not. Regardless, the Company only recommends products or services the Company believes will add value to its users. The Hormone Puzzle Society and Dr. Kela will receive up to 30% affiliate commission depending on the product that is sponsored on the show. For sponsorship opportunities, email HPS Media at media@hormonepuzzlesociety.com

If you've ever leaked when you laughed, jumped, or sneezed–or felt like your core disappeared after pregnancy, injury, or into perimenopause–you're not alone. This week, fitness specialist Leah Keller joins us to unpack deep core dysfunction: what causes it, and why healing it changes far more than just your abs. Leah's breakthrough came when she realized she could help women actually heal the separation between their abdominal muscles–known as diastasis recti–even years after giving birth. Clients who came for core work started reporting that they'd stopped leaking, that sex felt better, that back pain eased, and that their bodies finally felt like their own again– issues they never mentioned at the start. She explains exactly how fixing the deep core resolves problems women didn't even know were connected. We'll give detailed descriptions of the exercises. You can also watch this one on YouTube to see the exercise demonstrations as well as the anatomical illustrations referenced in this episode, showing the difference between a healthy midline and one with significant diastasis recti separation.Leah Keller is a certified personal trainer specializing in core and pelvic floor health, and co-founder of Every Mother (formerly The Dia Method). Her approach earned medical validation in a 2013 Weill Cornell pilot study — published in the American Journal of Obstetrics and Gynecology — and was further supported by a 2021 Hospital for Special Surgery trial in the Journal of Women's & Pelvic Health Physical Therapy. She has been featured as a women's health expert by NPR, Goop, and Good Morning America. You can find Leah's published studies, resources, and learn more about her work at leahkeller.comSign up for our FREE Feisty 40+ newsletter: https://feisty.co/feisty-40/Join us at Feisty Fest September 18-20, 2026: https://feisty.co/events/feisty-fest/Learn More about our 2026 Feisty Events, including Bike Camps and Cycling Trips: https://feisty.co/events/Follow Us on Instagram:Feisty Menopause: @feistymenopauseHit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099Support our Partners: Eternal - Get 15% off their services with code FEISTY15 at https://eternal.coMidi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Hettas: Use code STAYFEISTY for 20% off at https://hettas.com/ Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ Wahoo: Use the code FEISTY2026 to get a free Headwind Smart Fan (value $300) with the purchase of a Wahoo KICKR RUN at https://shorturl.at/WVhdr

Words matter, and equally as important, our actions matter. Sometimes the words opportunistic salpingectomy (OPS or OS) are used interchangeably with risk-reducing salpingectomy (RRS). However, these are two completely different items. In fact, there are 4 very important differences between the two. In the April 2026 AJOG, there's a new Clinical Opinion on this very topic. Listen in for details.1. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 2007 Feb;31(2):161-9. 2. ACOG CO 774; 20193. NCCN, Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. Updated 2026-03-12.4. ACOG Practice Bulletin No. 147: Lynch Syndrome.Obstetrics and Gynecology. 20145. Falconer H, Yin L, Grönberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. 2015 Jan 27;107(2):dju410. doi: 10.1093/jnci/dju410. PMID: 25628372.6. Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. Fertil Steril. 2014 Jul;102(1):192-198.e3. doi: 10.1016/j.fertnstert.2014.03.041. Epub 2014 May 10. PMID: 24825424; PMCID: PMC4074555.7. Wilke RN, Pennington KP, Gootzen TA, Steenbeek MP, de Hullu JA, Long KC, Blank SV, Swisher EM, Lu KH, Norquist B. Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution. Am J Obstet Gynecol. 2025 Nov 1:S0002-9378(25)00820-8. doi: 10.1016/j.ajog.2025.10.044. Epub ahead of print. PMID: 41183726.

Platelet-rich plasma (PRP) injections do not have formal FDA approval for specific clinical indications. PRP is regulated as an autologous blood product and is used "off-label" in clinical practice. However, there is substantial clinical evidence supporting its use for certain dental surgeries and musculoskeletal conditions, particularly lateral epicondylitis, knee osteoarthritis, and plantar fasciitis. The American Medical Society for Sports Medicine notes that PRP is primarily used to treat tendinopathies and osteoarthritis, though clinical efficacy results remain mixed due to variability in PRP formulations and preparation methods. As of now, there are no FDA approved uses for PRP for gynecologic use, although there has been some evidence of possible benefit in vulvar dermatoses and possiblt ovarian function enhancement. But what about its use in the vagina for sexual pleasure? Injecting into the anterior vaginal wall (around the famed G-Spot location) is nothing new. Over a decade ago, a TV show introduced the masses to the “G-Spot amplication” shot which injected collagen to that area. But there was no data for this. Well, we are back to this idea in a new RCT in the Green Journal. Can PRP light up the vaginal fires of pleasure? Listen in for details. 1. Clarke, Bayley MD; Gaddam, Neha MD; Garcia, Bobby MD; Iglesia, Cheryl B. MD; Podolsky, Robert PhD; Dieter, Alexis A. MD. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstetrics & Gynecology ():10.1097/AOG.0000000000006256, March 19, 2026. | DOI: 10.1097/AOG.00000000000062562. Finnoff JT, Awan TM, Borg-Stein J, et a American Medical Society for Sports Medicine Position Statement: Principles for the Responsible Use of Regenerative Medicine in Sports Medicine. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine. 2021. 3. Alsousou J, Ali A, Willett K, Harrison P. The Role of Platelet-Rich Plasma in Tissue Regeneration.Platelets. 2012.

INTRODUCING Behind the Knife OBGYN Oral Board Review!The oral boards aren't just about knowledge—they are about executing under pressure. This course is designed to give you the structure and confidence to command the room. We have curated 98 high-yield scenarios covering the "Big Three" of the exam: Obstetrics, Gynecology, and Office Practice. Whether it's a surgical emergency or a complex clinic workup, we will walk you through exactly how to articulate your plan, defend your decisions, and pass this exam.Each scenario includes 2 parts. The first part is a perfectly executed scenario.  If you are able to achieve this level of performance in your preparation you are sure to pass the oral exam with flying colors. The second part introduces high-yield commentary to each scenario. This commentary includes tips and tricks to help you dominate the most challenging scenarios in addition to practical, easy-to-understand teaching that covers the most confusing topics. We are confident you will find this unique, dual format approach a highly effective way to prepare for the test.Please check out the preview episodes below that include Parts A and B, with and without commentary.This course includes access to our Oral Board Simulator.  Step into the hot seat and experience the pressure of the real exam and receive detailed, actionable feedback with the most advanced oral board prep available.   3-Month Purchase - 10 exams 6-Month Purchase - 22 exams 12-Month Purchase - 46 exams Learn More: https://app.behindtheknife.org/premium/obgyn-oral-board-reviewDOMINATE THE DAY!

Podcast family, welcome to Quickie #4. This one will be fun: A. Medicine changes, and changes fast. I trained with and learned the Grannum grading placental system (grades 0-III based on ultrasound appearance). Is that still a thing? We recently found a “grade III placenta at 34 weeks” as an incidental finding. Is there specific management considerations for this? Listen in for details. B. What do we do when a patient has “two GBS results” in one pregnancy hat are discordant. Listen in for that as well!1. Jaiman S, Romero R, Pacora P, et al. Disorders of Placental Villous Maturation Are Present in One-Third of Cases With Spontaneous Preterm Labor. Journal of Perinatal Medicine. 2021. 2. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2017. Sentilhes L, Sénat MV, Ancel PY, et al. Prevention of Spontaneous Preterm Birth: Guidelines for Clinical Practice From the French College of Gynaecologists and Obstetricians (CNGOF).3. Brink LT, Roberts DJ, Wright CA, et al. Placental Pathology in Spontaneous and Iatrogenic Preterm Birth: Different Entities With Unique Pathologic Features. Placenta. 2022. 4. Chitlange SM, Hazari KT, Joshi JV, Shah RK, Mehta AC. Ultrasonographically Observed Preterm Grade III Placenta and Perinatal Outcome.International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics. 1990. 5. Mirza FG, Ghulmiyyah LM, Tamim H, et al. To Ignore or Not to Ignore Placental Calcifications on Prenatal Ultrasound: A Systematic Review and Meta-Analysis. The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2018. 6. Quinlan RW, Cruz AC, Buhi WC, Martin M. Changes in Placental Ultrasonic Appearance. II. Pathologic Significance of Grade III Placental Changes. American Journal of Obstetrics and Gynecology. 1982. 7. Karen M. Puopolo Group B Streptococcal Disease. https://orcid.org/0000-0002-5581-8825; Published February 25, 2026 N Engl J Med 2026;394:896-905ACOG 797

When people think of gynecology, they usually think of care that happens for older teens and adults, from birth control to pregnancy to menopause. But there's a whole world of gynecologic conditions that affect young girls and adolescents, too. Dr Nichole A Tyson + Dr. Joseph Sanfilippo, giants in the field of Pediatric Adolescent Gynecology, join us for a wide ranging conversation about painful periods, blood disorders, PCOS, endometriosis, MRKH, and STDs. Show Notes: ⁠NASPAG⁠ Watch the full episode on Youtube! Join the LESS AWKWARD MEMBERSHIP HUB Go to Quince.com/AWKWARD for free shipping on your order and three hundred and sixty-five -day returns.  Download the FREE Playbook for Getting Your Kid to Talk Order our book This Is So Awkward Check out all our speaking and curriculum at www.lessawkward.com and our super comfy products at www.myoomla.com To bring us to your school or community email operations@lessawkward.com To submit listener questions email podcast@lessawkward.com Produced by Peoples Media Learn more about your ad choices. Visit podcastchoices.com/adchoices

IUDs are under the umbrella of long-acting, reversible contraceptives, and they’re the oldest one of these in use today. Research: Baldauf, P et al. “A Report on the Hysteroscopic Removal of a Gräfenberg Ring After Almost Fifty Years in Utero.” Geburtshilfe und Frauenheilkunde vol. 74,11 (2014): 1023-1025. doi:10.1055/s-0034-1383130. https://pmc.ncbi.nlm.nih.gov/articles/PMC4245252/ Case Western Reserve University. “Intrauterine device (IUD).” https://artsci.case.edu/dittrick/online-exhibits/history-of-birth-control/contraception-in-america-1950-present-day/intrauterine-device-iud/ Cooper, James Fryer. “Technique of contraception: the principles and practice of anti-conceptional methods.” Day-Nichols Inc., Publishers. 1928, 1930. https://archive.org/details/techniqueofcontr0000jame/ Corbett, Megan and Brandy Bautista. “A History: The IUD.” Reproductive Health Access Project. 3/20/2024. https://www.reproductiveaccess.org/2024/03/a-history-the-iud/ Curtis, Kathryn M. et al. “U.S. Selected Practice Recommendations for Contraceptive Use, 2024.” Centers for Disease Control. 8/8/2024. https://www.cdc.gov/mmwr/volumes/73/rr/rr7303a1.htm Dickinson, Robert L. et al. “Contraception: A Medical Review of the Situation.” American Journal of Obstetrics and Gynecology 1924-11: Vol 8 Iss 5. https://archive.org/details/in.ernet.dli.2015.50850/page/n585/ Edwards, Baylee A., "Ernst Gräfenberg (1881–1957)". Embryo Project Encyclopedia ( 2022-11-17 ). ISSN: 1940-5030 https://hdl.handle.net/10776/13358 Fallas, Rebecca and Helen King. “IUD or not IUD? Did the Hippocratics invent the first intrauterine device?. Mistaking Histories. 7/18/2017. https://mistakinghistories.uk/2017/07/18/iud-or-not-iud-did-the-hippocratics-invent-the-first-intrauterine-device/ Fotinos, Diane J. “Gold Stemmed Pessaries: A Shadow of the Past.” UT Health. 9/11/2019. https://library.uthscsa.edu/2017/09/gold-stemmed-pessaries-a-shadow-of-the-past/ Goldstuck, Norman D. “Reducing Barriers to the use of the Intrauterine Contraceptive Device as a Long Acting Reversible Contraceptive.” African Journal of Reproductive Health / La Revue Africaine de la Santé Reproductive, December 2014, Vol. 18, No. 4 (December 2014). Via JSTOR. https://www.jstor.org/stable/24362040 Goodhue PA. The Dalkon Shield debate. Conn Med. 1983 Mar;47(3):138-41. PMID: 6851548. Haubacher, David. “The Checkered Past and Bright Future of Intrauterine Contraception in the United States.” Perspectives on Sexual and Reproductive Health , Mar. - Apr., 2002. Via JSTOR. https://www.jstor.org/stable/3030213 Homei, Aya. “Why did the Japanese Government take so long to approve the intrauterine contraceptive device?.” Reproductive biomedicine & society online vol. 6 45-54. 16 Oct. 2018, doi:10.1016/j.rbms.2018.09.002 Hubacher, David. “The Checkered History and Bright Future of Intrauterine Contraception In the United States.” Perspectives on Sexual and Reproductive Health. Vol. 34, Issue 2. https://www.guttmacher.org/journals/psrh/2002/03/checkered-history-and-bright-future-intrauterine-contraception-united-states Hutchings, Jane E. et al. “The IUD After 20 Years: A Review of Worldwide Experience.” International Family Planning Perspectives, Vol. 11, No. 3 (Sep., 1985). https://www.jstor.org/stable/2947998 Jones, R. W., et al. “Clinical Experience With The Dalkon Shield Intrauterine Device.” The British Medical Journal, vol. 3, no. 5872, 1973, pp. 143–45. JSTOR, http://www.jstor.org/stable/25420726. Accessed 5 Mar. 2026. Klapperich, Catherine M. “From the Dalkon Shield to Britney Spears’ IUD: Why Diverse Teams Need to Be Involved in Contraceptive Design.” The Brink. Boston University. 7/1/2021. https://www.bu.edu/articles/2021/from-the-dalkon-shield-to-britney-spears-iud-why-diverse-teams-need-to-be-involved-in-contraceptive-design/ Lopes-Garcia, E. A., Carmona, E. V., Monteiro, I., & Bahamondes, L. (2023). Assessment of pain and ease of intrauterine device placement according to type of device, parity, and mode of delivery. The European Journal of Contraception & Reproductive Health Care, 28(3), 163–167. https://doi.org/10.1080/13625187.2023.2189500 Margulies, Lazar. “History of Intrauterine Devices.” Bull. N. Y. Acad. Med. Vol. 51, No. 5, May 1975. Museum of Contraception and Abortion. “Tenrei Ota (1900-1985).” https://muvs.org/en/topics/pioneers/tenrei-ota-1900-1985-en/ Oppenheimer, W.. “Prevention of pregnancy by the graefenberg ring method.” American Journal of Obstetrics & Gynecology, Volume 78, Issue 2, 446 – 454. https://www.ajog.org/article/0002-9378(59)90203-0/abstract Peipert, Jeffrey F. “Lippes loop and the first IUDs: lessons from a bygone era.” American Journal of Obstetrics & Gynecology, Volume 219, Issue 2, 127 – 128. https://www.ajog.org/article/S0002-9378(18)30488-5/fulltext Peipert, Jeffrey F. “Lippes loop and the first IUDs: lessons from a bygone era.” American Journal of Obstetrics & Gynecology, Volume 219, Issue 2, 127 – 128 . https://www.ajog.org/article/S0002-9378(18)30488-5/fulltext Thiery, M. “Pioneers of the intrauterine device.” The European Journal of Contraception and Reproductive Health Care. Volume 2, Number 1, March 1997. The Parthenon Publishing Group International Publishers. Thomsen, Russel J. “An Atlas of Intrauterine Contraception.” Hemisphere Publishing Company. 1982. Tietze, Christopher and Sarah Lewit. “Intra-Uterine Contraceptive Devices: Proceedings of the Conference, April 30-May 1, 1962, New York City.” Exerpta Medica Foundation. Willingham, Emily. “A ‘Simple’ Piece of Plastic.” American Scientist. May-June 2012. https://www.americanscientist.org/article/a-simple-piece-of-plastic World Health Organization. “Selected practice recommendations for contraceptive use.” Fourth Edition. https://iris.who.int/server/api/core/bitstreams/582c8182-f4b1-406b-b5e7-d81c1870df93/content See omnystudio.com/listener for privacy information.